In 31 tumor types (excluding mesothelioma, as its mutation data were not available), we found that CHD6 was mutated in more than 5% of five tumor types, namely uterine, stomach, bladder, colorectal cancers, lung adenocarcinoma, and melanoma. Here, CHD6 is linked to neoplasm.